Catalyst Pharmaceuticals, Inc. v. Canada (Attorney General), 2022 FC 292
| Jurisdiction | Federal Jurisdiction (Canada) |
| Court | Federal Court (Canada) |
| Citation | 2022 FC 292 |
| Date | 10 March 2022 |
-
- This document is available in original version only for vLex customers
View this document and try vLex for 7 days - TRY VLEX
- This document is available in original version only for vLex customers
8 practice notes
-
Table of Cases
...Pharmaceuticals v Canada (Health), 2021 FC 505 ......................259, 260 Catalyst Pharmaceuticals, Inc v Canada (Attorney General), 2022 FC 292 ...... 255 CE Jamieson & Co (Dominion) v Canada (Attorney General), 37 CCC (3d) 193 , 46 DLR (4th) 582 .......................................
-
Data Protection
...prohibition or two distinct prohibitions, remains a matter of debate. In Catalyst Pharmaceuticals, Inc v Canada (Attorney General ), 2022 FC 292, the Federal Court suggests that these are two distinct prohibitions, such that a submission whose iling was not prohibited by C.08.004.1(3)(a) of......
-
Akme Poultry, Butter & Eggs Distributors Inc v. Canada (Public Safety and Emergency Preparedness), 2023 FC 1368
...decision-maker by compelling the decision-maker to reach a specific conclusion (Catalyst Pharmaceuticals, Inc v Canada (Attorney General), 2022 FC 292 at para 194), I would think especially where the assessment to be made is highly technical and fact‑specific, and ought to be perform......
-
2023 Year In Review: Life Sciences In Canada
...Drugs Regulations. An NOC was then issued for Médunik's RUZURGI shortly after, sparking two judicial reviews by Catalyst (2021 FC 505 and 2022 FC 292 under appeal in this decision) against the issuance of an NOC for RUZURGI. Catalyst argued that RUZURGI's reference to studies found in the U......
Request a trial to view additional results
2 cases
-
Akme Poultry, Butter & Eggs Distributors Inc v. Canada (Public Safety and Emergency Preparedness), 2023 FC 1368
...decision-maker by compelling the decision-maker to reach a specific conclusion (Catalyst Pharmaceuticals, Inc v Canada (Attorney General), 2022 FC 292 at para 194), I would think especially where the assessment to be made is highly technical and fact‑specific, and ought to be perform......
-
Canada (Attorney General) v. Catalyst Pharmaceuticals, Inc., 2023 FCA 3
...I. Background [1] This decision concerns an appeal and a cross-appeal from a decision of the Federal Court (per Justice Martine St-Louis, 2022 FC 292, the Decision) that granted an application for judicial review of a decision of the Minister of Health (the Minister), setting aside the Mini......
4 firm's commentaries
-
2023 Year In Review: Life Sciences In Canada
...Drugs Regulations. An NOC was then issued for Médunik's RUZURGI shortly after, sparking two judicial reviews by Catalyst (2021 FC 505 and 2022 FC 292 under appeal in this decision) against the issuance of an NOC for RUZURGI. Catalyst argued that RUZURGI's reference to studies found in the U......
-
Federal Court Sets Aside Minister Of Health's Approval Of RUZURGI For The Second Time Over Data Protection Dispute
...Health to issue market authorization for the amifampridine drug RUZURGI. In Catalyst Pharmaceuticals, Inc. v. Canada (Attorney General), 2022 FC 292, the FC held unreasonable the Minister's interpretation and application of the data protection provisions set out in the Food and Drug Regulat......
-
Federal Court Sets Aside Decision By The Minister Of Health To Issue RUZURGI NOC For The Second Time
...amifampridine phosphate), and sent the matter back for a new determination: Catalyst Pharmaceuticals, Inc v Canada (Attorney General), 2022 FC 292. As previously reported, Catalyst Pharmaceuticals, Inc (Catalyst) filed a new drug submission (NDS) for FIRDAPSE one month before Médunik filed ......
-
Federal Court Of Appeal Upholds Inapplicability Of Data Protection
...and again remitted the matter to the Minster for further redetermination (see Catalyst Pharmaceuticals, Inc v Canada (Attorney General), 2022 FC 292). This most recent Federal Court decision was appealed by both The Federal Court of Appeal's decision The Federal Court of Appeal concluded th......
2 books & journal articles
-
Table of Cases
...Pharmaceuticals v Canada (Health), 2021 FC 505 ......................259, 260 Catalyst Pharmaceuticals, Inc v Canada (Attorney General), 2022 FC 292 ...... 255 CE Jamieson & Co (Dominion) v Canada (Attorney General), 37 CCC (3d) 193 , 46 DLR (4th) 582 .......................................
-
Data Protection
...prohibition or two distinct prohibitions, remains a matter of debate. In Catalyst Pharmaceuticals, Inc v Canada (Attorney General ), 2022 FC 292, the Federal Court suggests that these are two distinct prohibitions, such that a submission whose iling was not prohibited by C.08.004.1(3)(a) of......